Protriptyline

This classification denotes a tricyclic antidepressant with the molecular formula C19H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4NDU154T12, chemically known as 7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene but generally known as protriptyline, which bears US NIH Compound Identifier 4976. European Medicines Agency schedules Protriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10145MIG. The term PROTRIPTYLINE is an International Non-Proprietary Name. World Health Organization schedules protriptyline in its Anatomical Therapeutic Chemical (ATC) Classification. PROTRIPTYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule protriptyline under HS 29214980 and SITC 51454. As of Q4 2014, PROTRIPTYLINE remains the US FDA Preferred Term for this commodity. Protriptyline bears US NLM identifiers UMLS ID C0033743 and NCI Concept Code C61913. SMILES: N(CCCC1c2c(C=Cc3c1cccc3)cccc2)C.